FADS2 Knockout HEK293 Cell Line

FADS2 Knockout HEK293 Cell Line
Cat.No.:

EDC09656

Species:

Human

Cell Name:

HEK293

Gene:

FADS2

Gene ID:

9415

Size:

1×10⁶cells

FADS2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC09656
Product Name FADS2 Knockout Cell Line(HEK 293)
Cell Line HEK293
Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293
Gene FADS2
NCBI Gene ID
Gene Synonyms D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13
Summary
The protein encoded by this gene is a member of the fatty acid desaturase (FADS) gene family. Desaturase enzymes regulate unsaturation of fatty acids through the introduction of double bonds between defined carbons of the fatty acyl chain. FADS family members are considered fusion products composed of an N-terminal cytochrome b5-like domain and a C-terminal multiple membrane-spanning desaturase portion, both of which are characterized by conserved histidine motifs. This gene is clustered with family members at 11q12-q13.1; this cluster is thought to have arisen evolutionarily from gene duplication based on its similar exon/intron organization. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
Associated Diseases Non-tumor
Morphology Adherent
Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS
Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying FADS2 (Δ6-desaturase, fatty acid desaturase 2)'s role as a critical enzyme in long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis or modeling FADS2 polymorphism effects on PUFA metabolism. The Knockout line is the standard tool for asking whether FADS2 is required for these processes — FADS2 catalyzes the Δ6-desaturation step in PUFA biosynthesis (ALA → SDA in ω-3 pathway; LA → GLA in ω-6 pathway), generating precursors for downstream elongation and Δ5-desaturation (FADS1) to produce EPA, DHA (ω-3) and arachidonic acid (ω-6). Overexpression is useful for studying FADS2 gain-of-function effects. For lipid metabolism research, the EDITGENE FADS2 Knockout in HEK293 enables study of LC-PUFA biosynthesis. FADS2 polymorphisms are associated with serum PUFA levels and ethnic variation in PUFA capacity (Inuit, South Asians have FADS2 variants affecting PUFA metabolism). Rescue with wild-type or catalytically-dead FADS2 enables structure-function studies. The knockout is valuable for studying ω-3/ω-6 PUFA metabolism, dietary PUFA requirements in FADS2-deficient contexts (DHA dietary necessity), and FADS2 polymorphism pharmacogenomic studies.
Primary applications: • PUFA biosynthesis: lipid mass spectrometry analysis of ω-3 (ALA, SDA, EPA, DHA) and ω-6 (LA, GLA, AA) fatty acid levels in FADS2-null versus rescued cells. • Δ6-desaturase activity: in vitro and cellular Δ6-desaturase activity assays. • FADS2 polymorphism studies: rescue with FADS2 polymorphic variants (e.g., rs174575) for pharmacogenomic studies of PUFA metabolism. • DHA dietary requirement: assessment of cellular DHA-dependent processes in FADS2-null cells, where DHA must be obtained from diet. EDITGENE recommends this model for researchers investigating ω-3/ω-6 PUFA metabolism, FADS2 polymorphism pharmacogenomics, and dietary lipid requirement biology.
Yes. FADS2 rescue experiments require attention to ER membrane targeting: • Construct design: use a codon-modified FADS2 sequence with a small C-terminal tag (FLAG, HA). FADS2 has N-terminal cytochrome b5-like domain, central diiron-binding catalytic region, and ER membrane-anchoring hydrophobic regions — preserve all elements. • ER localization validation: confirm endoplasmic reticulum localization before functional assays. • Catalytically-dead rescue: histidine cluster mutations affecting Fe coordination abolish desaturase activity. • Polymorphism rescue: FADS2 polymorphic variants (e.g., rs174575) enable pharmacogenomic studies. • Functional readout: rescue should restore Δ6-desaturation activity measured by ¹³C-ALA conversion to SDA or LA conversion to GLA. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: